Rare diseases
Investigational molecules
Locations
215 Church Street, 06510-1803, United States
Biohaven Therapeutics Ltd. funds clinical research in refractory focal onset epilepsy and idiopathic generalized epilepsy with generalized tonic-clonic seizures, with attention to seizure control, treatment response, and overall safety in adults living with difficult-to-manage epileptic conditions.
The sponsor’s epilepsy portfolio reflects interest in therapies aimed at reducing seizure burden and addressing unmet needs in chronic neurological disorders.
Biohaven Therapeutics Ltd. runs clinical trials in conditions such as Partial seizures, Parkinson's disease, Idiopathic generalised epilepsy, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaAustriaAustriaAustria
DenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
